NOT KNOWN DETAILS ABOUT DCK DRUG

We subsequently designed a far more distinct probe, [18F]CFA, which was used in The present study To judge dCK action in tumors when treated with a little molecule dCK inhibitor. This probe can be remaining analyzed in a very clinical demo at our establishment To guage modifications in dCK exercise subsequent most cancers immunotherapy 18. PET prob